Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.
about
Antigen-based immunotherapy for autoimmune disease: current statusOral tolerance to food proteinRecombinant Lactococcus lactis can make the difference in antigen-specific immune tolerance induction, the Type 1 Diabetes caseThe nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cellsLow dose native type II collagen prevents pain in a rat osteoarthritis modelThe cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasionInduction of tolerance by oral administration of beta-tubulin in an animal model of autoimmune inner ear disease.Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.The application of gene therapy in autoimmune diseases.New therapies in development for autoimmune diseases: their rationale for combination treatment.Role of glycopeptide-specific T cells in collagen-induced arthritis: an example how post-translational modification of proteins may be involved in autoimmune disease.Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis.Bench to bedside: new approaches to the immunotherapy of uveitic disease.Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis).Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis.Collagen epitope expression on B cells is sufficient to confer tolerance to collagen-induced arthritisA cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.Antigen-driven bystander suppression after oral administration of antigens.Changes in microarchitectural characteristics at the tibial epiphysis induced by collagen-induced rheumatoid arthritis over timeImmunomodulatory strategies for celiac disease.Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritisExperimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance.Nutritional Approach for Relief of Joint Discomfort: A 12-week, Open-case Series and Illustrative Case Report.Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis.Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study.Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxinSuppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggeringAntigen-driven peripheral immune tolerance. Suppression of organ-specific autoimmune diseases by oral administration of autoantigens.Clinical potential of antigen-specific therapies in type 1 diabetes.Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in miceInduction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat.Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patientsProtective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulinTreating arthritis by immunomodulation: is there a role for regulatory T cells?Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.
P2860
Q26852915-18314F50-1FE5-4FEB-AD41-885F7D918659Q27026259-27A7DDD7-B0BA-4E55-8144-88618CD030A7Q27028100-D736728B-8692-4AF8-9B9A-E2BF370DA46FQ28143755-5CC97197-0D27-4701-87EA-0CCB320DE919Q28387689-CCE48344-FBC2-4B25-819C-467B9DE0958AQ28573570-7C0E985D-0809-4FD3-B5AA-D6A1B76AA04DQ30480826-6FD27089-91DD-4188-85E0-626C50FBDC47Q33713407-89AA9C39-97DC-4845-9977-61FAD2D78998Q33840979-3C537603-C72F-4246-9D07-025DC79249BFQ34309745-7C3D3D4B-92F2-4521-87D4-B806B5B04B94Q34420007-425AF7DB-1773-4E09-85C2-0273C30D42FFQ34554878-30BE7D6C-FCFE-4EA0-8479-784252047EEAQ34993229-7427F4DB-98A6-497B-8BBE-329A6D310984Q35040784-447F2AC7-8D70-451C-AD23-F6E2C1588B65Q35612665-7E540910-9A83-4456-8C0F-43FC839E53E7Q35637379-6D58A094-6CAD-430F-B504-607AB9EE2A40Q35878983-71E3048D-6C58-4B40-9836-41717C42BE5AQ36012266-29C297E3-4267-4019-8132-291B4D4BDE0AQ36052152-C2CDFA94-40EB-493A-811E-B3D1F5BB8788Q36140954-C7B9275D-D278-45CB-9975-85741F13B913Q36230404-E7480620-63FB-4713-91C7-8544F222F6D8Q36283679-4FD2FD98-AABF-46D9-94D8-FDDAC2471643Q36327386-BD2316D6-FCEC-4C88-B304-169B4B61C8F8Q36357044-3E30F340-2DBB-4952-B658-29417853B7DCQ36366774-F2945764-849D-459A-BC13-8D21C103981DQ36462631-2DCA84C2-D111-49BC-9F8B-86FEE71BEA75Q36480993-648DD558-5D7B-4ABB-8CB7-94D8A5CBE49CQ36517447-5BD1BF5F-A4FE-4CB6-9F37-D28FE6CF0511Q36771712-F01BEBFA-70A8-456E-A6F5-DA69A08F61CEQ36778446-D10E5F6A-AA4E-4D40-8435-6FD6C1054188Q36968782-3AAA1BE4-601D-488F-BBCE-F62AFDD7BF2CQ37088212-3BD44C4D-B3B6-4F15-8962-56C5ACE88CE5Q37147228-9F5B6D60-9D51-44A3-8198-114F7805E38BQ37163546-834BAA14-9482-48CA-8398-2C4686BC2B9EQ37356987-65DF5D19-A15B-48D7-BB8A-723B63A268D6Q37468752-7FE9E274-1178-4EEA-A9DA-3F1DC229DA2CQ37494112-0C5CB521-27CA-4367-A196-1AEA5209342DQ37622936-47CF1ACF-FC17-49AA-9DC6-909716E90C9BQ37750140-337E249D-D066-4A61-A0A4-F4308CBB1BA5Q37890928-016871DB-68A2-44F1-9FE9-127CB7929E86
P2860
Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1986
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suppression of type II collage ...... n of soluble type II collagen.
@en
Suppression of type II collage ...... n of soluble type II collagen.
@nl
type
label
Suppression of type II collage ...... n of soluble type II collagen.
@en
Suppression of type II collage ...... n of soluble type II collagen.
@nl
prefLabel
Suppression of type II collage ...... n of soluble type II collagen.
@en
Suppression of type II collage ...... n of soluble type II collagen.
@nl
P2093
P2860
P356
P1476
Suppression of type II collage ...... n of soluble type II collagen.
@en
P2093
C Nagler-Anderson
G J Thorbecke
G W Siskind
M E Robinson
P2860
P304
P356
10.1073/PNAS.83.19.7443
P407
P577
1986-10-01T00:00:00Z